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OBJECTIVE—Recent data demonstrated that glucose sensing
in different tissues is initiated by an intracellular redox signaling
pathway in physiological conditions. However, the relevance of
such a mechanism in metabolic disease is not known. The aim
of the present study was to determine whether brain glucose
hypersensitivity present in obese Zu ¨cker rats is related to an
alteration in redox signaling.
RESEARCH DESIGN AND METHODS—Brain glucose sens-
ing alteration was investigated in vivo through the evaluation of
electrical activity in arcuate nucleus, changes in reactive oxygen
species levels, and hypothalamic glucose-induced insulin secre-
tion. In basal conditions, modiﬁcations of redox state and
mitochondrial functions were assessed through oxidized gluta-
thione, glutathione peroxidase, manganese superoxide dis-
mutase, aconitase activities, and mitochondrial respiration.
RESULTS—Hypothalamic hypersensitivity to glucose was char-
acterized by enhanced electrical activity of the arcuate nucleus
and increased insulin secretion at a low glucose concentration,
which does not produce such an effect in normal rats. It was
associated with 1) increased reactive oxygen species levels in
response to this low glucose load, 2) constitutive oxidized
environment coupled with lower antioxidant enzyme activity at
both the cellular and mitochondrial level, and 3) overexpression
of several mitochondrial subunits of the respiratory chain
coupled with a global dysfunction in mitochondrial activity.
Moreover, pharmacological restoration of the glutathione hy-
pothalamic redox state by reduced glutathione infusion in the
third ventricle fully reversed the cerebral hypersensitivity to
glucose.
CONCLUSIONS—The data demonstrated that obese Zu ¨cker
rats’ impaired hypothalamic regulation in terms of glucose sens-
ing is linked to an abnormal redox signaling, which originates
from mitochondria dysfunction. Diabetes 58:2189–2197, 2009
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t is well established that the brain has a critical role
in regulating the energy needs of the body (1). Both
carbohydrate and lipid stores are monitored by the
brain using metabolic, hormonal, and neural signals
from the periphery (2,3). These signals enter the brain and
trigger neuroendocrine and autonomic responses that
maintain energy homeostasis (4,5). Among the metabolic
signals, glucose has long been identiﬁed and the physio-
logical relevance of hypothalamic glucoresponsive neu-
rons has been directly demonstrated (6). The molecular
mechanisms underlying the glucose responsiveness of
neurons in the hypothalamus exhibit -cell analogy involv-
ing GLUT2, glucokinase, and KATP channels (7–10). Re-
cently, a novel signaling pathway involving mitochondrial
reactive oxygen species (mROS) was identiﬁed (11–13).
Both pancreatic and hypothalamic studies pointed to
mROS as a necessary signal to initiate the response to
“glucose sensing” (e.g., insulin secretion). These studies
suggest that a ﬁnely controlled mROS production depend-
ing on mitochondrial activity might be considered as a
master physiological messenger in metabolite-sensitive
cells.
Obesity is a major health problem in Western societies
coupled with a high risk of developing insulin resistance.
Rodent experimental models of obesity display impaired
metabolic and hormonal brain sensing (14). Recent work
demonstrated that the alteration of the hypothalamic
glucose-sensing mechanism was sufﬁcient to induce dra-
matic effects on energy balance correlated to mitochon-
drial abnormalities (6,15). Zu ¨cker rats exhibit a strong
presence of obesity and an insulin resistance with dra-
matic autonomic disturbances, that is, modiﬁcation of the
sympathovagal balance (16,17). This model is also charac-
terized by cerebral hypersensitivity to glucose, which
initiates an abnormal vagus-induced insulin secretion
(18,19). In this study, we set out to determine the role of
redox signaling in hypothalamic hypersensitivity to glu-
cose in this model of obesity. In addition, hypothalamic
electrical activity has been characterized and shown to be
correlated to aberrant mROS levels, redox state, and
mitochondrial activity. Finally, restoration of the redox
state fully reversed the cerebral hypersensitivity to
glucose.
RESEARCH DESIGN AND METHODS
Genetically obese (fa/fa) and lean (Fa/?) male Zu ¨cker rats (7 weeks old;
Charles River) were housed in a controlled environment (12-h light/dark cycle,
lights on at 7:00 A.M., 22°C) and fed ad libitum (Harlan, Gannat, France).
Surgeries and experiments were performed under pentobarbital anesthesia
(50 mg/kg, Centravet, Dinan, France) except where noted. All procedures
involving rats were in accordance with the European Communities Council
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were carried out after a period of 3 h fasting beginning at time of lights on.
Intracarotid injection of glucose toward the brain. A catheter was
inserted into the carotid artery and pushed on 5 mm in the cranial direction.
A bolus of 3 or 9 mg/kg glucose in 100 l of adapted saline concentration was
injected toward the brain in 30 s. Saline and glucose in saline solutions were
equiosmolar (300 mOsm).
Neuronal activity recordings. Multiunit recordings within arcuate were
made using a monopolar platinum electrode (Phymep, Paris, France) as
previously described (20). Rats were placed in a stereotaxic apparatus (David
Kopf), and arcuate nucleus was targeted according to coordinates obtained
from Paxinos stereotaxic atlas: 3.1 mm posterior to bregma, 8.7 mm under
the brain surface, and 0.4 mm from the midline. Action potentials were
displayed and saved on a computer after initial ampliﬁcation through a
low-noise ampliﬁer (BIO ampliﬁer, AD Instrument, Rabalot, France). Data
were digitized with a PowerLab/4sp digitizer. Signals were ampliﬁed 10
5 and
ﬁltered at low and high frequency cutoffs of 100 and 1,000 Hz and monitored
with the Chart 4 computer program. Baseline unit activity was recorded for 10
min before infusion of a compound. Multiunit recordings were made in
response to a 100 l intracarotid ipsilateral injection of either saline or
glucose.
Osmotic pump implantation. Cannula (Plastics one, Phymep) was targeted
to the third ventricle (2.6 mm posterior to the bregma and 10.0 mm below the
dura). Four days later, only rats with dipsogenic effects (angiotensin II, 60
pmol, 3 l; Sigma-Aldrich, St. Quentin Fallavier, France) were used for
intracerebroventricular infusions. Four days later, the osmotic minipump (1
l/h, 3 days, model 1003D; Alzet, Charles River, St. Germain sur l’Arbresle,
France) ﬁlled either with PBS-HEPES (5 mmol/l) or with glutathione (1 mol/l)
(21) (Sigma-Aldrich) was implanted under isoﬂurane gas anesthesia. Experi-
ments were performed 3 days later (Fig. 1).
Mitochondrial extraction. Animals were killed by cervical dislocation.
Brains were removed and immediately immersed in ice-cold PBS-HEPES (5
mmol/l). Dissected tissues were immersed for 15 min in a buffer A (10 mmol/l
HEPES, 10 mmol/l KCl, 240 mmol/l sucrose, protease inhibitor cocktail tablet
[complete Mini; Roche, Meylan, France]) and homogenized with a dounce
homogenizer (7.5 l/10 mg tissues of buffer A). The homogenate was resus-
pended in 125 l/10 mg tissues of buffer A and centrifuged (1,000  g, 10 min,
4°C). The supernatant was centrifuged (12,000  g, 10 min, 4°C). The
remaining mitochondrial pellet was resuspended either in 8.2 l/10 mg tissues
of buffer B (10 mmol/l HEPES, 420 mmol/l NaCl, 0.5 mmol/l Dithiothreitol, and
protease inhibitor cocktail tablet) for Western blot analysis or in 16.5 l/10 mg
tissues of Mitomed R05 solution (0.5 mmol/l EGTA, 60 mmol/l K-Lactobionate,
20 mmol/l Taurine, 10 mmol/l KH2PO4, 3 mmol/l MgCl2, 110 mmol/l sucrose, 1
g/l free fatty acid BSA, 20 mmol/l HEPES, and pH  7.1) for O2 consumption
measurement.
Immunoblotting analysis of respiratory chain complexes. Mitochondrial
proteins (10 g) were separated on SDS-PAGE 15% for OXPHOS immunola-
beling, using a cocktail of antibodies that recognizes respiratory chain
complexes. After transfer onto a Hybond membrane (Amersham, GE Health-
care, Ramonville, France), blocking was performed for1ha troom tempera-
ture in 5% nonfat milk prepared in Tris-buffered saline with tween 0.2%.
Membranes were probed with 1/500 of mouse anti-OXPHOS (Mitosciences,
Euromedex, Souffelweyersheim, France) overnight at 4°C. Speciﬁc bands of
OXPHOS were detected using a goat anti-mouse peroxidase-conjugated
secondary antibody (Amersham) revealed with a chemioluminescence kit
(Amersham) and exposed to autoradiographic ﬁlms. Immunolabeled bands
were quantiﬁed from densitometry analysis.
O2 consumption measurement on mitochondria. Oxygen consumption
was measured using a respirometer (Oxygraph-2k; Oroboros Instruments,
Innsbruck, Austria) as previously described (22). Measurements were taken
with stirring (750 rpm) in 2 ml of Mitomed R05 at 30°C. The medium was
equilibrated with air for 30 min, and mitochondria (200 g) were transferred
into the respirometer’s glass chambers. Mitochondrial respiration was stimu-
lated by the successive addition of substrates 1, 5, and 20 mmol/l glutamate to
achieve the apparent state 2. Then, 0.1 mmol/l ADP was added to achieve the
apparent state 3 respirations. Next, 5 mol/l carboxy-atractylate (CAtr) was
added to block ATP synthesis and achieve the apparent state 4 respiration.
Finally, 1 mol/l potassium cyanide (KCN) was added to obtain the nonmito-
chondrial O2 consumption. Mitochondrial states 2, 3, and 4 were calculated by
subtracting the nonmitochondrial O2 consumption from apparent states. The
respiratory control ratio (RCR) was the state 3-to-state 4 ratio. Uncoupled
respiration was assessed using glutamate (20 mmol/l), CAtr (5 mol/l), and
palmitate (300 mol/l) stimulation. Carbonyl cyanide m-chlorophenylhydra-
zone (CCCP, 0.4 mol/l), a chemical uncoupler, was used to measure the
maximal respiration. Oxygen consumption was calculated using DataGraph
software. Media were prepared according to the guide provided by Oroboros
Instruments. Technical sheets are available on the company Web site at
http://www.oroboros.at/.
ROS level measurement. One minute after glucose injection, rats were
decapitated, brains quickly removed, and hypothalami and thalami dissected
on ice-cooled glass plate. Brain areas were immediately frozen in nitrogen
liquid and stored at 80°C. ROS were assessed with the 2–7-dichloroﬂuores-
cein diacetate probe (23) (Invitrogen, Cergy Pontoise, France) and quantiﬁed
in a ﬂuorescent plate reader at 535 nm under excitation at 490 nm using a
microplate reader (Victor Wallace, Perkin Elmer, Courtaboeuf, France).
Aconitase activity measurement. Maximum aconitase activity measure-
ment was performed using a protocol already described (24). The photo-
chrome was measured at 525 nm using the UVIKON Spectrophotometer 922.
Enzymatic and nonenzymatic antioxidant. Tissue pieces were homoge-
nized in a lysis saline solution (3 mmol/l EDTA, 150 mmol/l KCl, and pH  7.4).
Homogenates (50 l) mixed with 450 l of 5% metaphosphoric acid were then
centrifuged (1,500  g, 10 min, 4°C). Final supernatant was used for
glutathione and antioxidant enzyme assays. Glutathione assay was performed
by reverse-phase high-performance liquid chromatography (HPLC) as previ-
ously described (25). Total glutathione (GSx) was the sum of reduced
glutathione (GSH) and twofold oxidized glutathione (GSSG) concentrations
([GSx]  [2  GSSG]  [GSH]). We then calculated the redox state of
glutathione as (GSSG/GSx)  100. Superoxide dimutase (SOD) activity
(manganese superoxide dismutase [MnSOD] and Cu/Zn SOD) was assayed
using the inhibition of pyrogallol autoxidation (26). One enzymatic unit of
SOD activity was deﬁned as the amount of enzyme that inhibited pyrogallol
autoxidation by 50%. Glutathione peroxidase (GPx) activity was measured
using t-butylhydroperoxide as substrate (27). One enzymatic unit of GPx
activity corresponds to the oxidation of 1 mmol of NADPH/min.
Mitochondrial quantiﬁcation. Citrate synthase assay was measured accord-
ing to the procedure of Srere (28): one enzymatic unit of citrate synthase was
equal to the reduction of 1 mmol of 5–5-dithiobis-2-nitrobenzoic acid per min.
Cytochrome oxidase activity. Fresh hypothalami were homogenized in cold
buffer (0.25 mol/l sucrose, 5 mmol/l TES, and pH  7.2) and cyclooxygenase
activity measured as previously described (29).
Protein assay. Concentration of samples was determined using the DC
protein assay kit (Biorad, Marnes la Coquette, France) according to the
manufacturer’s instructions.
Plasma glucose and insulin concentrations. Plasma was isolated from the
blood collected at the rat-tail blood vessels. Glucose and insulin were
determined using a glucose analyzer (One Touch II) and an ultrasensitive
ELISA kit (Eurobio, Paris, France), respectively.
Statistical analysis. Results are presented as means  SE. Comparisons
between groups were carried out for each parameter using Prism 4.0 software
(GraphPad Software). A two-way ANOVA was applied ﬁrst to detect interac-
tions between genotype and treatment. When genotype did not produce any
signiﬁcant effect, one-way ANOVA was then applied; otherwise, groups were
analyzed independently using Student’s or Mann-Whitney U tests when
appropriate. After one-way ANOVA, multiple comparisons of means were
further computed with Newman-Keuls test. Both Bartlett’s and Shapiro Wilk’s
tests were also applied to check equality in variance and normality of
distribution, respectively. For some parameters, nonparametric Kruskal-
Wallis and Mann-Whitney U tests were used when appropriate, that is,
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FIG. 1. Schematic representation of experimental procedure for reduced glutathione infusion (GSH-EE, reduced glutathione ethyl ester).
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nonpaired Student’s t test was applied. Signiﬁcant difference was noted *, **,
or *** on the graphic representation when P value was 	0.05, 0.01, and 0.001,
respectively.
RESULTS
Seven-week-old obese Zu ¨cker rats were hyperinsulinemic
(142.70  2.68 vs. 26.05  3.26 U/ml) but normoglycemic
(5.96  0.07 vs. 5.75  0.15 mmol/l) (Table 1).
Obese rats exhibit brain hypersensitivity to glucose.
We conﬁrmed the cerebral hypersensitivity exhibited by
obese rats in response to glucose. Thus, 9 mg/kg glucose
injection into the carotid artery toward the brain caused a
rapid and transient increase of plasma insulin (50 U/ml)
1 min after the carotid injection in lean and obese rats (Fig.
2A) (18,30). When a similar test was performed with a
lower dose of glucose (3 mg/kg), insulin secretion did not
occur in lean rats. By contrast, in obese Zu ¨cker rats, this
lower dose of glucose was sufﬁcient to produce a rapid
and transient increase in plasma insulin concentration.
Amplitude and delay of this 3 mg/kg glucose-stimulated
insulin secretion were similar to those observed with a
glucose dose of 9 mg/kg in lean rats (P  0.5737) (Fig. 2A).
These results demonstrate that obese animals exhibit
brain glucose hypersensitivity. This intracarotid glucose
injection did not raise systemic glucose levels at any time
during the test (Fig. 2B). Therefore, the insulin response is
only because of cerebral glucose sensing and cannot result
from peripheral effects.
Stimulation of multicellular hypothalamic electrical
activity at the low glucose dose in obese rats. We
previously showed that the activation of extracellular
hypothalamic activity in arcuate nucleus in response to
glucose was required to initiate insulin secretion in normal
rats (12). Here, we explored the effect of 3 mg/kg glucose
on extracellular arcuate nucleus electrical activity in both
phenotypes. Basal glycemia at the time of recording was
5.91  0.33, 6.05  0.22, 5.89  0.26, and 5.90  0.59
mmol/l for lean and obese NaCl-injected rats and lean and
obese 3 mg/kg glucose–injected rats, respectively. In lean
rats, 3 mg/kg glucose induced a slight increase in arcuate
electrical activity compared with saline injection (33%,
P 	 0.01). It also induced a signiﬁcant increase in electri-
cal events in obese animals when compared with saline
injection (71%, P 	 0.001) (Fig. 3) that differ signiﬁcantly
from the ones observed in lean rats injected with glucose
(P 	 0.01). Moreover, in contrast to obese rats, 3 mg/kg
glucose–induced electrical activity was not associated
with insulin secretion in lean rats.
TABLE 1
Characteristics of Zücker rats
Body (g)
Insulinemia
(U/ml)
Glycemia
(mM)
Lean 221.50  5.64 26.05  3.26 5.75  0.15
Obese 258.17  7.23*** 142.70  2.68 5.96  0.07
Basal values of body weight, insulinemia, and glycemia are ex-
pressed as means  SE (7-week-old rats). Signiﬁcant differences
according to the unpaired Student’s t test (n  7) compared with
lean littermates. ***P 	 0.001.
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FIG. 2. Hypothalamic hypersensitivity to glucose in the obese Zu ¨cker rat. A: Insulin secretion in response to glucose. Plasma insulin in obese and
lean rats in response to saline (dotted line) or 3 mg/kg (G3, dash line) or 9 mg/kg (G9, black line) glucose injection toward the brain. Results are
expressed as means  SE ( from basal insulinemia at t  0). Asterisk indicates signiﬁcant differences according to independent statistical
analysis using Mann-Whitney U test at t  1 min, n  6–9 per genotype (*P < 0.05 and ***P < 0.001). B: No change in glycemia during the
glucose-sensing test. Glycemia in response to saline (dotted line) or 3 mg/kg (G3, dash line) or 9 mg/kg (G9, black line) glucose injection toward
the brain. Results are expressed as means  SE ( from basal glycemia at t  0). No signiﬁcant differences were detected using two-way ANOVA
analysis at t  1 min (n  6–9 per genotype).
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response to the low glucose load. We measured ROS
levels after saline or glucose injection. For this purpose,
rats were injected through the carotid artery toward the
brain with either the low dose of glucose or saline and
killed 1 min after the injection (when insulin secretion
occurs). ROS levels were assessed in both hypothalamus
and thalamus. Interestingly, the basal constitutive ROS
level, that is, assessed after saline intracarotid injection,
was similar in both genotypes (Fig. 4). Glucose stimulation
did not induce a signiﬁcant change in hypothalamic ROS
levels in lean rats. However, ROS levels were signiﬁcantly
increased (37%, P 	 0.05) in obese rats injected with 3
mg/kg glucose when compared either with obese animals
injected with saline or with lean rats injected with the
same glucose load (P 	 0.05, Fig. 4). Thus, low glucose
stimulation mediates an increase in ROS levels only in
obese rats. No such increase in ROS levels was found in
thalamus, suggesting a regional speciﬁcity for this response
(Fig. S1A, available in an online appendix at http://diabetes.
diabetesjournals.org/cgi/content/full/
db09-0110/DC1).
Abnormal ROS signaling is correlated to an alter-
ation in the hypothalamic redox state. ROS level
results from the balance between ROS production and
detoxiﬁcation. We measured enzymatic and nonenzymatic
antioxidants in basal conditions (i.e., without glucose
stimulation). The glutathione redox state, deﬁned as
GSSG-to-GSx ratio, as it is the major antioxidant that
scavenges ROS, was oxidized twofold (P 	 0.001) more in
the hypothalamus of obese rats (Fig. 5A). Glutathione
peroxidase activity was found to be signiﬁcantly lower in
the hypothalamus of obese rats (266.0  28.7 vs. 166.0 
21.5; P 	 0.01 in lean vs. obese rats) (Fig. 5B). Glutathione
peroxidase activity did not vary in the thalamus (Fig. S1B).
The mitochondrial MnSOD activity was also decreased in
obese rats (0.0102  0.0009 vs. 0.0065  0.0008 enzymatic
unit per milligrams proteins; P 	 0.01 in lean vs. obese
rats) whereas extramitochondrial CuZnSOD was not sta-
tistically different between the two genotypes (Fig. 5C and
D). This strongly suggests a mitochondrial defect in anti-
oxidant enzyme activity in the hypothalamus of obese rats.
This is reinforced by the activity of aconitase, an enzyme
of the Krebs’s cycle sensitive to mROS and thus revealing
the intramitochondrial redox state (31). This activity was
signiﬁcantly decreased (39%; P 	 0.001) in the hypothal-
amus of obese Zu ¨cker rats (Fig. 5E). Altogether, these
results demonstrate that the hypothalamic redox state is
lower in obese rats than in lean rats, regardless of the
intracellular compartment studied.
Hypothalamic mitochondria exhibit increased activ-
ity in response to substrates. We explored the cyto-
chrome c oxidase activity (cyclooxygenase [COX],
complex IV), which reﬂects the oxidative potential of the
mitochondrial respiratory chain. COX activity was signiﬁ-
cantly increased (51%; P 	 0.01) in the hypothalamus of
obese Zu ¨cker rats (Fig. 6A). To get further insight into the
hypothalamic mitochondrial function, oxygen consump-
tion by the electron transport chain was explored on
isolated mitochondria (Fig. 6B). We performed titrations
with glutamate (1, 5, and 20 mmol/l) to determine substrate-
driven respiration. We highlighted a greater increase in the
O2 ﬂux in response to glutamate in obese rats compared
with lean ones. This increase was signiﬁcant for each dose
of glutamate (O2 ﬂux in lean vs. obese rats: 1 mmol/l,
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FIG. 3. Increased hypothalamic electrical activity in response to the
low glucose dose. A: Multiunit sample recordings of arcuate nucleus
neuronal activity in lean and obese Zu ¨cker rats after the carotid
injection of saline (Nacl) or 3 mg/kg glucose (G3). B: Quantiﬁcation of
multiunit activity recorded in arcuate nucleus. Data are expressed as
means  SE corresponding to the percentage of the number of spikes
measured in lean rats injected with saline. The bar graph depicts the
electrical activity during the ﬁrst minute after carotid injection of
saline (NaCl) or 3 mg/kg glucose (G3) in lean (white bar) and in obese
(Ob) rats (black bar). Asterisks indicate signiﬁcant differences accord-
ing to the unpaired Student’s t test (n  6 per genotype) (*P < 0.05,
**P < 0.01, and ***P < 0.0001).
FIG. 4. Hypothalamic ROS production of obese rats in response to the
low glucose load. ROS production in the hypothalamus in response to
saline (NaCl) or to 3 mg/kg glucose (G3) injection toward the brain
measured in lean (white bar) and in obese (Ob) rats (black bar). ROS
level assessed in hypothalamic area by oxidation of dichloroﬂuorescein
diacetate probe 1 min after intracarotid injection. Data are expressed
as means  SE (percentage of the ROS ﬂuorescence observed in obese
rats injected with saline). Asterisk indicates signiﬁcant differences
according to the post hoc Newman-Keuls test (n  8–11 per genotype)
(*P < 0.05).
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mmol/l, 4.70  1.54 vs. 11.63  2.30 pmol/[s  mg], P 	
0.05; and 20 mmol/l, 7.81  1.38 vs. 20.23  5.57 pmol/[s 
mg], P 	 0.05), revealing a hypersensitivity to this sub-
strate at the level of the respiratory chain. State 3
(substrates/ADP-driven) respiration was assessed with
saturating ADP concentration. The O2 ﬂux 13.25  2.43
pmol/(s  mg) versus 28.67  5.69 pmol/(s  mg) in lean
and obese rats, respectively, was increased in obese rats
(P 	 0.05). CAtr, an ATP-ADP exchange inhibitor, was
then added to obtain the ADP-independent resting state 4,
whereas respiration is only driven by substrates. State 4
was signiﬁcantly enhanced in obese rats. Finally, the RCR
(RCR  state 3/state 4) in lean rats (1.50  0.52) was not
signiﬁcantly different from obese rats (1.50  0.19). The
total respiratory capacity induced by CCCP was signiﬁ-
cantly increased in obese rats (36.43  1.00 pmol/
[s  mg]) compared with lean ones (28.80  2.44 pmol/
[s  mg]), P 	 0.05 (Fig. 6C). Next, we examined
uncoupling respiration. Stimulation of uncoupling proteins
with 300 mol/l palmitate (Palm) did not reveal differences
between lean (25.39  2.17 pmol/[s  mg]) and obese
(27.83  3.86 pmol/[s  mg]) rats (Fig. 6D). This result
reveals no difference in uncoupling respiration. In conclu-
sion, these results indicate an increase in hypothalamic
mitochondria activity at the complex I and IV, as revealed
with glutamate assay and COX activity measurement. The
increase in total respiratory capacity further supports
these data. No difference was found regarding these pa-
rameters in the thalamus (Fig. S1C–E).
Expression of the ﬁve complexes of the respiratory
chain was examined. Both nuclear (30 kDa subunit of
complex II, core protein 2 subunit of complex III, and the

 subunit of complex V) and mitochondrial (ND6 subunit
of complex I and subunit 1 of complex IV) complexes
encoded were quantiﬁed at the protein level by Western
blotting (Fig. 6E). The expression of complexes I, II, III,
and IV (COX) was increased in hypothalamic mitochon-
dria from obese rats (177, 153, 128, and 159%). Complex V
expression (105%) was unchanged (Fig. 6F). These results
indicate an increased quantity of most complexes of the
electron transport chain in the mitochondria of obese rats.
These differences were not caused by a change in
mitochondrial number because citrate synthase activity
was identical in both genotypes (Fig. 6G).
Restoration of hypothalamic redox state normalizes
the response to glucose load in obese rats. We decided
to normalize the glutathione redox state in obese rats to
test whether this could explain impaired ROS production
stimulated by the low glucose load (3 mg/kg). Therefore,
reduced glutathione (GSH) was intracerebroventricularly
infused over 3 days using an osmotic minipump. Well-
being of the animals (weight gain and food intake) was
preserved during the infusion (Fig. S2A and B). HPLC
analysis revealed that the GSH chronic intracerebroven-
tricular infusion was efﬁcient to restore GSH redox state
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it did not reverse mitochondrial function as measured on
glutamate titration by oxygraphy (Fig. 7B). ROS levels and
pancreatic insulin secretion were measured after the in-
tracarotid 3 mg/kg glucose injection in glutathione-infused
obese rats. Obese glutathione-infused rats did not have
any more exacerbated ROS levels in response to the low
glucose load and exhibited ROS levels similar to those of
normal rats (Fig. 7C). Regarding the insulin response, it
showed a full restoration of their sensitivity to glucose
because their insulin peak was completely abolished in
response to 3 mg/kg glucose. This result indicates a master
role of mROS levels in response to glucose, at least for
the nervous control of insulin secretion (Fig. 7D).
DISCUSSION
It has recently been demonstrated that glucose sensing
was triggered by an intracellular redox signaling pathway
in physiological conditions in the pancreas as well as in
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a mechanism in metabolic disease is not known. We
hypothesized that an alteration in redox signaling in the
brain could participate in metabolic diseases. To test this
hypothesis, we explored redox signaling in the Zu ¨cker rat.
These rats are obese, insulin-resistant, and dyslipidemic
but normoglycemic. One original feature of this model is
its hypothalamic hypersensitivity to glucose (18). We
speciﬁcally aimed to understand whether this hypersensi-
tivity to glucose present in obese Zu ¨cker rats could be
related to an alteration in redox signaling. For the ﬁrst
time, we revealed that this hypersensitivity was associ-
ated, within the hypothalamus, with 1) an increased ROS
level in response to the low glucose load, 2) a constitutive
oxidized environment at both the cellular and mitochon-
drial level, and 3) an overexpression of several mitochon-
drial subunits of the respiratory chain, coupled with a
global dysfunction in the mitochondrial activity. Moreover,
pharmacological restoration of the hypothalamic redox
state fully reversed the altered cerebral hypersensitivity to
glucose. Altogether, these data suggest that this impaired
metabolic regulation in the obese Zu ¨cker rat is linked to an
abnormal redox signaling that originates from mitochon-
drial dysfunction.
In normal animals, hypothalamic glucose sensing pro-
motes an increase in hypothalamic electrical activity and
rapid and transient vagal-mediated insulin secretion
(12,19). Moreover, we previously demonstrated that a key
step in these events requires redox signaling because they
were abolished when mROS were quenched (12). The
hypersensitivity to glucose of obese Zu ¨cker rats has been
demonstrated as an abnormal insulin response occurring
after a low glucose load (3 vs. 9 mg/kg) that is inefﬁcient in
lean littermates (18). We conﬁrmed this data regarding the
peripheral insulin release and reinforced the notion of
cerebral hypersensitivity to glucose in obese rats as as-
sessed by the hypothalamic glucose-stimulated electrical
activity. Indeed, we brought to light an increased level in
the whole multicellular electrical activity in the arcuate
nucleus of obese rats in response to 3 mg/kg glucose.
Contrary to lean rats, this enhanced glucose-stimulated
electrical activity was associated with the insulin response
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the arcuate nucleus in response to 3 mg/kg glucose was
high enough to promote insulin secretion in obese rats.
Electrical activity was recorded under pentobarbital anes-
thesia that has depressive effects on nervous activity (32),
thus suggesting a much greater effect on vigil rats. The
multicellular recordings do not allow a distinction be-
tween direct versus presynaptic effects. However, numer-
ous arcuate glucose-sensitive neurons have the ability to
directly detect a change in glucose concentration (33).
This cerebral hypersensitivity to glucose may explain the
elevated parasympathetic tone that consequently contrib-
utes to the development of hyperinsulinemia in the obese
Zu ¨cker rat (17,34).
In obese rats, there was a signiﬁcant increase in ROS
levels within the hypothalamus under low glucose stimu-
lation at the time when plasma insulin increases. ROS
concentration results from the balance between produc-
tion and scavenging. The latter depends on the intracellu-
lar redox state (35,36). Glutathione redox (oxidized-to-
total form ratio) constitutes an accurate indicator of the
cellular redox state because glutathione is in large amount
in cells (1–5 mmol/l) and considered as the major ROS
detoxifying system (37). It has a pivotal and synergetic
role with many other antioxidants by reducing pro-oxidant
forms (36). In the hypothalamus of obese rats, glutathione
was oxidized twofold more in basal conditions. Decreased
GPx activity in the hypothalamus from obese rats further
conﬁrmed that basal redox state was deeply modiﬁed in
this area. To gain insight into the oxidative environment in
the mitochondria, we evaluated MnSOD and aconitase
activity. MnSOD and aconitase, an enzyme involved in the
Krebs cycle and sensitive to ROS, are exclusively located
in the mitochondria (31). Their activities were decreased
in the hypothalamus of the obese Zu ¨cker rat. In contrast,
Cu/ZnSOD located in the cytosol did not vary. Altogether,
these data reveal a constitutive oxidative environment in
the hypothalamus of obese Zu ¨cker rats regardless of the
intracellular compartment (cytosol or mitochondria).
These results are in line with numerous studies showing a
drop in the antioxidant defenses such as reduced glutathi-
one, 
-tocopherol, and catalase in several tissues of obese
Zu ¨cker rats (38,39). Finally, the more oxidized cellular
environment within the hypothalamus of obese rats could
partly explain why an increased ROS level in response to
the low glucose load is not buffered as in lean rats.
ROS are produced by electron leakage during mitochon-
drial metabolism, and the rate of their formation is en-
hanced as the mitochondrial metabolism increases (40–
42). We explored the mitochondrial function in the
hypothalamus of Zu ¨cker rats. First, the oxidative ability of
the respiratory chain as determined by the cytochrome c
oxidase activity, the total respiratory function as assessed
with saturating substrate, and the chemical uncoupling
were all signiﬁcantly increased in the hypothalamus of
obese rats. Second, the apparent afﬁnity of the mitochon-
drial respiration for substrate was higher in obese rats as
assessed by glutamate titration. Third, altered expression
of mitochondrial complexes (I to IV) was increased in
obese rats. These results are consistent with previous
studies showing an increased oxidative capacity in the
muscle of such rats, associated with an increasing number
of functional units in the mitochondrial respiratory chain
(43,44). No change in mitochondrial number was observed
in the hypothalamus of obese rats as revealed by citrate
synthase activity assay. Furthermore, it may be stressed
that all these alterations are speciﬁc to the hypothalamus
because no change was observed in the thalamus. Taken
together with the absence of complex V modiﬁcations, the
alterations seen between complexes I to IV may result in
an enhancement in respiratory chain constraints (45). As
an improved mitochondrial metabolism promotes ROS
production under stimulation, this could represent the
molecular basis of the abnormal increased ROS levels
within the hypothalamus of obese rats in response to a low
glucose load, in concert with the higher oxidized environ-
ment. One can speculate that the excessive mitochondrial
ROS production might be a primary and causal link with
the overoxidation of the redox state.
Recent observations from our laboratory and others
(12,15,46) argue that ROS are part of hypothalamic activity
control for the regulation of energy homeostasis. To date,
ROS have been proposed as messengers in brain glucose
and lipid sensing (12,46). For example, fasting abolished
increased ROS in brain lipid sensing by increasing hypo-
thalamic mitochondrial uncoupling (46); ghrelin signals
are ROS-dependently integrated in NPY/AgRP neurons
(15). Moreover, this latest study suggests that ROS signal-
ing takes place in the neuronal population, although other
cell types remain to be explored.
Here we show for the ﬁrst time that dysfunction in
hypothalamic redox signaling could be the molecular basis
for impaired brain glucose sensing and might explain some
features of the metabolic defects in obese rats such as
hyperinsulinism. This has been strengthened by the exper-
iment using a pharmacological approach (GSH treatment)
that normalized the glutathione redox state. Indeed, such
normalization reversed the increased ROS level as well as
peripheral insulin secretion in response to a low glucose
load (3 mg/kg). These ﬁndings highlight the necessity for a
ﬁne and balanced level of ROS dependent on the mito-
chondrial metabolism and the redox environment, which
is required to trigger the appropriate redox signaling in
response to glucose.
In summary, we demonstrated that the cerebral hyper-
sensitivity to glucose in obese rats results from both
impaired redox signaling and increased mitochondrial
respiratory chain activity that lead to excessive ROS
levels. One can postulate that these increased ROS levels
activate redox signaling involving ROS-sensitive voltage-
dependent channels (47,48). Changes in channel confor-
mation will then modulate electrical activity that in turn
triggers vagal-mediated insulin secretion. To determine
whether hypothalamic mitochondrial dysfunction is of
primary importance in the etiology of the hyperinsulinism
in obesity, long-term treatment aiming to normalize redox
state would provide interesting clues.
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